This document is a routine and planned risk assessment of the 2013-2014 seasonal influenza in EU/EEA countries. Active circulation of influenza has started late in Europe in the 2013-2014 season, with a different timing across EU/EEA countries, states the annual ECDC risk assessment on seasonal influenza.
Between 2 December 2023 and 15 March 2024, highly pathogenic avian influenza (HPAI) A(H5) outbreaks were reported in domestic (227) and wild (414) birds across 26 countries in Europe.
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Based on a systematic literature review, ECDC assessed the efficacy, effectiveness and safety of newer and enhanced inactivated seasonal influenza (flu) vaccines among those 18 years or older. These assessed are MF59® adjuvanted, cell-based, high-dose, and recombinant haemagglutinin influenza vaccines.
This report provides an update on seasonal influenza immunisation policies and vaccination coverage rates in EU/EEA Member States for the 2012–13 influenza season.
Banners can be included in web page structures for the entire influenza season or as part of a post or feature article. These web banners are part of the "Communication guidelines on how to increase influenza vaccination uptake and promote preventive measures to limit its spread".
Banners can be included in web page structures for the entire influenza season or as part of a post or feature article. These web banners are part of the "Communication guidelines on how to increase influenza vaccination uptake and promote preventive measures to limit its spread".